Presented at the 10th Workshop on Recent Issues in Bioanalysis (WRIB), this presentation outlines the current best practices in commercial kit evaluation and validation for biomarker assays. Q² Solutions has the breadth and depth of biomarker expertise, tools and capabilities to prepare and implement strategies to help drug developers effectively gain a competitive advantage in commercial kit evaluation – helping ensure your success in clinical trials, regulatory approvals and new product launches. 

Download this presentation to see how Q² Solutions can be your partner of choice for any development program which requires identifying, designing and/or validating biomarkers, because we're able to go a step further to help you understand how these biomarkers can help deliver actionable insights for better health™.